Jump to navigation
A study led by Dr. Julie Bauman will be expanded to further investigate the safety and effectiveness of a personalized cancer vaccine.
UArizona researchers have developed a method of using ketamine in the treatment of Parkinson’s disease. The discovery has been licensed to Pharmather Inc. for development and commercialization.
Dr. Sairam Parthasarathy is one of 11 principal investigators for the National Institutes of Health Community Engagement Alliance Against COVID-19 Disparities.
Researchers have developed a rapid, simplified method for producing radio-labeling compounds used for PET scans.
UArizona researchers developed one of the most accurate COVID-19 antibody tests available and now have shown antibodies persist for months after infection, providing long-term immunity.
Antibodies normally fight viruses, but in the case of flaviviruses, they can make infections worse. UArizona Health Sciences immunologists took a closer look at antibody production to figure out why, which could lead to new methods of developing vaccines for flaviviruses.
Researchers found that SARS-CoV-2 can relieve pain, which may explain why nearly half of the people who get COVID-19 experience few or no symptoms.
A new study finds that menopause-induced changes to protective immune cells might contribute to the sharp increase in high blood pressure in postmenopausal women.
Green light therapy resulted in about a 60% reduction in the pain intensity of the headache phase and the number of days per month people experienced migraines.
A $2.8 million grant may help develop an improved therapeutic treatment for acute ischemic stroke patients to let them recover faster with fewer long-term complications.
